Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

UK to Invest up to £2.8M in Bioscience Research

Published: Thursday, April 17, 2014
Last Updated: Thursday, April 17, 2014
Bookmark and Share
The investment in collaborative feasibility studies aims to stimulate innovation across four technology areas that will enable and underpin UK growth.

The Technology Strategy Board, Invest Northern Ireland (Invest NI) and Highlands and Islands Enterprise (HIE) are to invest up to £2.75m in collaborative feasibility studies to stimulate innovation across four technology areas that will enable and underpin UK growth: advanced materials; biosciences; electronics, sensors and photonics, and information and communications technology (ICT). 

Projects will be led by a small or micro company, in collaboration with one or more business or research partners, with expected costs of £50k to £150k and last from six to 15 months. 

The bioscience proposals should be focused on one or more of the specific elements below: 

Characterisation and discovery tools 

  • commercial application of sequencing technologies focusing on genomics 
  • integration and exploitation of phenotyping technologies 
  • integration of 'omics technologies, such as integrating metabolomic, proteomic, genomic and phenomic data collection and interpretation capabilities 
  • biological imaging systems, biosensors, probes/ markers, diagnostic platforms. 

Production and processing 

  • metabolic engineering 
  • novel manufacturing processes for biological products and novel biological production systems 
  • formulation and delivery approaches for biological products, including biopharmaceuticals and functional foods. 

 Bioinformatics 

  •  approaches to organising, filtering and interpreting biological data, including biological system modelling, data visualisation and user-centred design. 

Projects should be focused on early-stage technical opportunities that: 

  • contain a significant level of technical risk, in that there is some level of uncertainty about how the proposed technical approach will work in practice 
  • involve companies carrying out most (if not all) of the research in-house. Projects should build a technical evidence base to enable progression to larger-scale projects. 

This competition opens on 6 May 2014, and the deadline for applications is noon on 25 June 2014.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

New Funding Scheme will Support Innovative Small Companies
Enable companies to research and develop new products, processes and services that could stimulate economic growth.
Tuesday, March 22, 2011
Scientific News
Genetic Cause of Rare Allergy
Institute has identified a genetic mutation responsible for a rare form of inherited hives induced by vibratory urticaria.
Mitochondria Shown to Trigger Cell Ageing
An international team of scientists has for the first time shown that mitochondria, the batteries of the cells, are essential for ageing.
Cancer Cells Kill Off Healthy Neighbours
Cancer cells create space to grow by killing off surrounding healthy cells, according to UK researchers working with fruit flies.
Validating the Accuracy of CRISPR-Cas9
IBS Researchers create multiplex Digenome-seq to find errors in CRISPR-Cas9 processes.
Cancer Drug Target Visualized at Atomic Resolution
New study using cryo-electron microscopy shows how potential drugs could inhibit cancer.
Genetic Mechanism Behind Cancer-Causing Mutations
Researchers at Indiana University has identified a genetic mechanism that is likely to drive mutations that can lead to cancer.
"Gene Fusion" Drives Childhood Brain Cancers
Study co-led by Penn scientists highlights potential targets for future cancer therapies.
Enzyme Links Age-Related Inflammation, Cancer
Researchers have shown that an enzyme key to regulating gene expression -- and also an oncogene when mutated -- is critical for the expression of numerous inflammatory compounds that have been implicated in age-related increases in cancer and tissue degeneration.
How to Unlock Inaccessible Genes
An international team of biologists has discovered how specialized enzymes remodel the extremely condensed genetic material in the nucleus of cells in order to control which genes can be used.
Viral Gene Editing System Corrects Genetic Liver Disease
Penn study has implications for developing safe therapies for an array of rare diseases via new gene cut-and-paste methods.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!